five

Synthesis and Biological Evaluation of New 3-Phenylthiazolidin-4-One and 3-Phenylthiazole Derivatives as Antimicrobial Agents

收藏
DataCite Commons2021-10-14 更新2024-07-28 收录
下载链接:
https://tandf.figshare.com/articles/dataset/Synthesis_and_Biological_Evaluation_of_New_3-Phenylthiazolidin-4-One_and_3-Phenylthiazole_Derivatives_as_Antimicrobial_Agents/11663526
下载链接
链接失效反馈
官方服务:
资源简介:
A new series of 3-phenylthiazolidin-4-ones <b>4a-h</b> and 3-phenylthiazoles <b>6a-i</b> were synthesized from the reaction of different 4-phenyl-3-thiosemicarbazone derivatives <b>3a-i</b> with dimethyl acetylenedicarboxylate and 4-bromophenacyl bromide, respectively. Preparation of 3-phenylthiazoles <b>6a-i</b> starting from 4-bromophenacyl bromide could be achieved through two pathways either directly or indirectly in which new intermediates <b>5a-i</b> were isolated. The <i>in vitro</i> antibacterial activities of the newly synthesized compounds were tested versus two panels of Gram-positive bacteria; (<i>Staphylococcus aureus</i>, <i>Bacillus subtilis</i>) and Gram-negative bacteria (<i>Escherichia coli</i>, <i>Pseudomonas aeuroginosa</i>). Also, these compounds were tested for their activities as anti-fungal versus a panel of two fungi (<i>Aspergillus flavus</i>, <i>Candida albicans</i>). Compounds <b>4d, 6a, 6d,</b> and <b>6f</b> showed excellent antimicrobial activity exceeded 90%. Compound <b>6d</b> had equivalent potency to Ampicillin in inhibiting the growth of (<i>Bacillus subtilis</i>) bacteria (% activity index= 100%). Most of the rest of compounds showed good antimicrobial activity (70–90%).

本研究分别以不同的4-苯基-3-氨基硫脲衍生物(4-phenyl-3-thiosemicarbazone derivatives)<b>3a-i</b>与乙酰二羧酸二甲酯(dimethyl acetylenedicarboxylate)、4-溴苯甲酰溴(4-bromophenacyl bromide)反应,合成了全新的3-苯基噻唑烷-4-酮(3-phenylthiazolidin-4-ones)<b>4a-h</b>与3-苯基噻唑(3-phenylthiazoles)<b>6a-i</b>系列化合物。以4-溴苯甲酰溴为起始原料制备3-苯基噻唑<b>6a-i</b>时,可通过直接法与间接法两条路径完成,其中间接法可分离得到全新的中间体<b>5a-i</b>。对上述新合成化合物开展了<i>体外(in vitro)</i>抗菌活性测试,受试菌株分为两类:革兰氏阳性菌(Gram-positive bacteria)包括<i>金黄色葡萄球菌(Staphylococcus aureus)</i>与<i>枯草芽孢杆菌(Bacillus subtilis)</i>;革兰氏阴性菌(Gram-negative bacteria)包括<i>大肠杆菌(Escherichia coli)</i>与<i>铜绿假单胞菌(Pseudomonas aeuroginosa)</i>。同时,针对两类受试真菌——<i>黄曲霉(Aspergillus flavus)</i>与<i>白色念珠菌(Candida albicans)</i>,测试了这些化合物的抗真菌活性。测试结果显示,化合物<b>4d</b>、<b>6a</b>、<b>6d</b>与<b>6f</b>展现出优异的抗菌活性,抑菌率超过90%。其中化合物<b>6d</b>在抑制<i>枯草芽孢杆菌(Bacillus subtilis)</i>生长方面的活性与氨苄青霉素(Ampicillin)相当,活性指数达100%。其余多数化合物均表现出良好的抗菌活性,抑菌率介于70%至90%之间。
提供机构:
Taylor & Francis
创建时间:
2020-01-20
二维码
社区交流群
二维码
科研交流群
商业服务